Apeloa Pharmaceutical Co Ltd (000739) — Cash Flow Reinvestment Rate
Apeloa Pharmaceutical Co Ltd (000739) has a Cash Flow Reinvestment Rate of 0.38x as of December 2025, reinvesting CN¥168.67 Million (capex CN¥166.73 Million plus investments CN¥1.94 Million) from operating cash flow of CN¥446.18 Million. See Apeloa Pharmaceutical Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Apeloa Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1998–2025)
Historical reinvestment intensity for Apeloa Pharmaceutical Co Ltd across 26 annual periods. For the full cash flow conversion analysis, see 000739 cash flow metrics.
Annual Cash Flow Reinvestment Rate for Apeloa Pharmaceutical Co Ltd (1998–2025)
Year-by-year capital reinvestment analysis for Apeloa Pharmaceutical Co Ltd. See Apeloa Pharmaceutical Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.35x | CN¥435.36 Million | CN¥1.23 Billion | CN¥386.21 Million | ▼ -17.0% |
| 2024 | 0.43x | CN¥515.11 Million | CN¥1.21 Billion | CN¥460.75 Million | ▼ -66.4% |
| 2023 | 1.27x | CN¥1.31 Billion | CN¥1.03 Billion | CN¥630.47 Million | ▲ +226.5% |
| 2022 | 0.39x | CN¥514.89 Million | CN¥1.33 Billion | CN¥509.11 Million | ▼ -70.1% |
| 2021 | 1.30x | CN¥794.48 Million | CN¥611.75 Million | CN¥701.92 Million | ▲ +96.6% |
| 2020 | 0.66x | CN¥699.74 Million | CN¥1.06 Billion | CN¥317.12 Million | ▲ +130.1% |
| 2019 | 0.29x | CN¥390.45 Million | CN¥1.36 Billion | CN¥31.85 Million | ▲ +30.6% |
| 2018 | 0.22x | CN¥183.02 Million | CN¥832.69 Million | CN¥81.62 Million | ▼ -82.6% |
| 2017 | 1.26x | CN¥264.82 Million | CN¥209.80 Million | CN¥163.42 Million | ▼ -63.9% |
| 2016 | 3.50x | CN¥631.12 Million | CN¥180.42 Million | CN¥331.35 Million | ▲ +240.8% |
| 2015 | 1.03x | CN¥452.75 Million | CN¥441.16 Million | CN¥452.06 Million | ▲ +49.4% |
| 2014 | 0.69x | CN¥540.22 Million | CN¥786.64 Million | CN¥540.22 Million | ▼ -74.1% |
| 2013 | 2.65x | CN¥505.01 Million | CN¥190.45 Million | CN¥505.01 Million | ▲ +162.3% |
| 2012 | 1.01x | CN¥339.59 Million | CN¥335.90 Million | CN¥339.59 Million | ▲ +41.4% |
| 2011 | 0.71x | CN¥289.21 Million | CN¥404.62 Million | CN¥289.21 Million | ▼ -38.1% |
| 2010 | 1.15x | CN¥139.81 Million | CN¥121.05 Million | CN¥139.81 Million | ▲ +156.9% |
| 2009 | 0.45x | CN¥93.66 Million | CN¥208.30 Million | CN¥93.66 Million | ▼ -87.8% |
| 2008 | 3.69x | CN¥349.04 Million | CN¥94.57 Million | CN¥349.04 Million | ▲ +455.7% |
| 2007 | 0.66x | CN¥115.70 Million | CN¥174.20 Million | CN¥115.70 Million | ▲ +96.7% |
| 2006 | 0.34x | CN¥53.84 Million | CN¥159.43 Million | CN¥53.84 Million | ▼ -75.7% |
| 2005 | 1.39x | CN¥121.65 Million | CN¥87.40 Million | CN¥121.65 Million | ▼ -40.4% |
| 2004 | 2.34x | CN¥111.07 Million | CN¥47.54 Million | CN¥111.07 Million | ▲ +179.4% |
| 2003 | 0.84x | CN¥88.09 Million | CN¥105.36 Million | CN¥88.09 Million | ▼ -95.0% |
| 2002 | 16.78x | CN¥47.23 Million | CN¥2.81 Million | CN¥47.23 Million | ▲ +3595.5% |
| 2000 | 0.45x | CN¥3.22 Million | CN¥7.08 Million | CN¥3.22 Million | ▼ -16.8% |
| 1998 | 0.55x | CN¥16.43 Million | CN¥30.10 Million | CN¥16.43 Million | — |